Skip to main content
Fig. 3 | BMC Psychiatry

Fig. 3

From: Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study

Fig. 3

Medication Satisfaction Questionnaire Satisfaction with Current Injectable Medication Itema, Aripiprazole Lauroxil Groupa. Patients were asked, “How satisfied are you with your current injectable medication?” Possible responses were very dissatisfied, somewhat dissatisfied, neither, somewhat satisfied, or very satisfied

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us